S 
32.31
+3.46%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$12.09bn
FY2016FY2025
Net income
$288.8m
FY2016FY2025
Free cash flow
$1.22bn
FY2016FY2025
Shareholders' equity
$8.81bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.09bn | $12.69bn | $12.45bn | $12.24bn | $11.85bn | $11.38bn | $10.90bn | $11.93bn | $12.39bn | $12.09bn |
| Gross profit | $10.56bn | $11.07bn | $10.88bn | $10.65bn | $10.27bn | $9.84bn | $9.21bn | $9.87bn | $10.20bn | $9.83bn |
| Research and development | $240.1m | $267.4m | $261.3m | $241.1m | $245.9m | $249.8m | $229.2m | $274.2m | $279.5m | $243.8m |
| Operating income | $953.7m | $1.53bn | $1.24bn | $1.13bn | $1.41bn | $913.0m | $698.1m | $589.7m | $2.62bn | $1.69bn |
| Net income | $288.8m | $884.1m | $773.4m | $645.3m | $1.70bn | $1.06bn | $628.5m | $2.21bn | $1.84bn | $1.19bn |
| Diluted earnings per share | 0.75 | 2.27 | 1.96 | 1.64 | 4.35 | 1.66 | 1.79 | 5.69 | 4.70 | 3.07 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $21.29bn | $21.58bn | $21.30bn | $22.14bn | $21.86bn | $33.88bn | $31.55bn | $29.96bn | $23.64bn | $22.13bn |
| Cash and short-term investments | $1.19bn | $1.66bn | $1.24bn | $1.50bn | $980.5m | $2.08bn | $1.60bn | $1.94bn | $1.57bn | $1.47bn |
| Total liabilities | $12.41bn | $13.22bn | $12.65bn | $13.55bn | $13.14bn | $16.63bn | $15.41bn | $14.16bn | $10.89bn | $10.74bn |
| Debt | $7.34bn | $7.61bn | $7.54bn | $7.84bn | $7.33bn | $8.60bn | $7.81bn | $6.83bn | $5.28bn | $5.21bn |
| Shareholders' equity | $8.81bn | $8.27bn | $8.05bn | $8.00bn | $8.19bn | $16.79bn | $16.24bn | $15.89bn | $12.62bn | $11.30bn |
| Shares outstanding | 383m | 389m | 394m | 393m | 392m | 641m | 350m | 389m | 392m | 386m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $2.80bn | $3.60bn | $3.50bn | $3.65bn | $3.56bn | $4.12bn | $2.82bn | $3.06bn | $2.73bn | $3.00bn |
| Capital spending | −$1.58bn | −$1.81bn | −$2.18bn | −$2.15bn | −$2.34bn | −$2.61bn | −$2.49bn | −$2.33bn | −$2.02bn | −$2.21bn |
| Free cash flow | $1.22bn | $1.79bn | $1.32bn | $1.49bn | $1.22bn | $1.51bn | $331.8m | $733.4m | $703.1m | $790.2m |
| Dividends paid | −$450.4m | −$582.8m | −$547.3m | −$639.3m | −$727.4m | −$524.9m | −$508.3m | −$499.4m | −$499.4m | −$499.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.08bn | $3.11bn | $3.06bn | $2.81bn | $3.07bn | $3.15bn | $3.19bn | $3.21bn |
| Gross profit | $3.08bn | $2.72bn | $2.68bn | $2.41bn | $3.07bn | $2.75bn | $2.21bn | $2.87bn |
| Operating income | $400.3m | $387.4m | $20.0m | $34.3m | $239.2m | $401.3m | $179.6m | $376.7m |
| Net income | $332.8m | $228.0m | $79.6m | −$111.9m | $63.4m | $257.7m | $242.3m | $190.2m |
| Diluted earnings per share | 0.88 | 0.61 | 0.21 | -0.29 | 0.17 | 0.67 | 0.62 | 0.49 |
| Cash from operations | — | $771.0m | $758.0m | $117.0m | $993.0m | $885.0m | $898.0m | $1.01bn |
| Capital spending | — | −$263.0m | −$515.0m | −$460.0m | −$228.0m | −$391.0m | −$664.0m | −$354.0m |
| Free cash flow | — | $508.0m | $243.0m | −$343.0m | $765.0m | $494.0m | $234.0m | $655.0m |
| Total assets | — | $20.92bn | $21.29bn | $20.44bn | $20.72bn | $21.16bn | $21.58bn | $20.84bn |
| Cash and short-term investments | — | $1.24bn | $1.19bn | $1.19bn | $1.81bn | $1.80bn | $1.66bn | $1.58bn |
| Debt | — | $6.47bn | $7.34bn | $7.66bn | $7.56bn | $7.55bn | $5.62bn | $7.19bn |
| Shareholders' equity | — | $8.98bn | $8.81bn | $8.28bn | $8.38bn | $8.36bn | $8.31bn | $8.30bn |
Financial ratios
Data as of 1 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 87.3% | 87.3% | 87.4% | 87.0% | 86.7% | 86.5% |
| Operating margin | 7.9% | 12.1% | 10.0% | 9.2% | 11.9% | 8.0% |
| Net margin | 2.4% | 7.0% | 6.2% | 5.3% | 14.4% | 9.4% |
| Return on equity | 3.3% | 10.7% | 9.6% | 8.1% | 20.8% | 6.3% |
| Return on assets | 1.4% | 4.1% | 3.6% | 2.9% | 7.8% | 3.1% |
| Free cash flow yield | 46713.2% | 56296.7% | 58360.8% | 59869.5% | 60934.8% | 42469.7% |
| Revenue growth | -4.7% | 1.9% | 1.8% | 3.3% | 4.1% | 4.4% |
| Earnings growth | -67.3% | 14.3% | 19.9% | -62.1% | 60.0% | 69.3% |
| Current ratio | 1.03x | 0.81x | 0.94x | 0.90x | 0.91x | 1.07x |
| Debt to equity | 0.74x | 0.81x | 0.83x | 0.86x | 0.79x | 0.47x |
| Equity ratio | 41.4% | 38.3% | 37.8% | 36.2% | 37.5% | 49.6% |
| Interest coverage | 3.47x | 4.96x | 4.57x | 5.01x | 6.88x | 4.85x |
| R&D as a share of sales | 2.0% | 2.1% | 2.1% | 2.0% | 2.1% | 2.2% |
| Buybacks as a share of market value | 2.4% | 1.3% | -0.4% | -0.1% | 38.9% | -83.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -0.4% | 1.2% | -0.0% |
| Operating income | -5.4% | 0.9% | -1.0% |
| Net income | -23.5% | -23.0% | -12.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 87.3% | 87.2% | 87.0% | 84.9% |
| Operating margin | 10.0% | 9.8% | 9.9% | 10.5% |
| Net margin | 4.7% | 5.2% | 7.4% | 9.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 27.3 | 9.3 | 10.9 | 12.5 | 6.1 | 14.5 | 12.7 | 4.6 | 5.8 | 6.7 |
| Price to sales | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 | 1.4 | 0.7 | 0.9 | 0.9 | 0.7 |
Market value over time
31 Oct 2016 to 30 Sept 2026, in USD
$14.03bn$13.38bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -10% | 2% | 4% | -27% | 15% | 6% | -14% | -4% | 27% | 10% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.